乳腺肿瘤专业医生决策的辅助工具——辅助在线  

Decision making adjuvant tools for breast cancer health care professionals---- Adjuvantonline

作　　者：申维玺[1] 郑涛[1] 

机构地区：[1]广东省深圳市人民医院肿瘤内科深圳市肿瘤研究所暨南大学第二临床医学院,广东深圳518020

出　　处：《世界肿瘤杂志》2010年第2期77-81,共5页Tumour Journal of the World

摘　　要：早期乳腺癌病人术后合理选择辅助化疗和内分泌治疗，需要权衡利弊。辅助在线可以帮助医生评估病人术后复发死亡的风险和接受辅助治疗可能带来获益的数值，对于早期乳腺癌病人术后辅助治疗的选择具有指导价值。Benefits and adverse effects of adjuvant therapies should be considered in the rational selection of adjuvant chemotherapy and endocrine therapy after the operation of patients with early breast cancer. Adjuvantonline can assist doctors in assessing the risk rate of relapse and mortality after operation and net number of clinical benefits made by adjuvant therapy. Adjuvantonline has a directive value in selecting the adjuvant therapies after operation of patients with early breast cancer.

关 键 词：乳腺肿瘤 治疗 辅助在线 

分 类 号：R737.9[医药卫生—肿瘤]